ICARE Social Media Post November 2020

ASCO Guideline Updates: Breast Cancer

The American Society of Clinical Oncology (ASCO) published updated guidelines for the management of hereditary breast cancer for the following gene carriers:
β€’ Consider breast-conserving therapy
β€’ Consider nipple-sparing mastectomy, if medically appropriate
β€’ Advanced breast cancer:
β«Έ PARP inhibitors (olaparib, talazoparib) preferred over non-platinum single agent chemotherapy
β«Έ Platinum agents are recommended versus taxanes
β€’ Mastectomy is advised
β€’ Radiation therapy is contraindicated except for those at risk for locoregional recurrence
For more information, check out the full article at: https://ascopubs.org/doi/full/10.1200/JCO.20.00299

Permanent link to this article: https://inheritedcancer.net/post112020/